跳至主要内容
临床试验/CTRI/2020/08/027209
CTRI/2020/08/027209已完成未知

To compare the efficacy and safety of Azilsartan versus Losartan in patients of hypertension

PIMS0 个研究点目标入组 105 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • New patients with hypertension i.e not on any antihypertensive therapy.
  • 2. Adult males and females of age 18 years or more.

排除标准

  • 1.Sitting clinic diastolic BP (DBP) >114ââ?¬Æ?mm Hg
  • 2.Patients already on anti-hypertensives.
  • 3.Patients with hypersensitivity to AZL or Losartan.
  • 4.Pregnant/ lactating women/ women planning to conceive.
  • 5.Evidence of severe renal disorder.
  • 6.Patients with hepatic insufficiencies.
  • 7.Patients unwilling or unable to comply with the study proceedings.
  • 8.Patients with severe bradycardia, cardiogenic shock, heart block, sick sinus syndrome, decompensated heart failure, bronchial asthma, hypothyroidism, CVA, CAD.
  • 9.Patients with other co morbidities like hyperthyroidism, anxiety disorders.
  • 10.Patients with refractory hypertension.

研究者

发起方
PIMS

相似试验